Innate Pharma S.A. Sponsored ADR (IPHA)
Market Closed
17 Jul, 20:00
$
1. 75
-0.02
-1.4085%
$
168.09M Market Cap
- P/E Ratio
- Div Yield
10,400 Volume
0 Eps
$ 1.77
Previous Close Investors:
Want to track IPHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IPHA Earnings Reports FAQ
What is the earnings per share (EPS) for IPHA?
The current EPS is 0.
What is the company's earnings growth rate?
Innate Pharma S.A. Sponsored ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Innate Pharma S.A. Sponsored ADR has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Innate Pharma S.A. Sponsored ADR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IPHA at this time, as Innate Pharma S.A. Sponsored ADR has no recent EPS data to calculate it.
